Clinical trials
Terminated Phase 1/2 Lymphoma, T-Cell, Peripheral trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Akeso | 1 |
| Antengene Corporation | 1 |
| Asana BioSciences | 1 |
| Bristol-Myers Squibb | 1 |
| Columbia University | 1 |
| Fox Chase Cancer Center | 1 |
| Jennifer Amengual | 1 |
| National Health Research Institutes, Taiwan | 1 |
| Northwestern University | 1 |
| University of Michigan Rogel Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 10 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Burkitt Lymphoma | 4 |
| Hodgkin Disease | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Lymphoma, Follicular | 4 |
| Lymphoma, Large-Cell, Anaplastic | 4 |
| Lymphoma, Mantle-Cell | 4 |
| Lymphoma | 3 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.